Latest Office News

XRF Scientific has delivered its strongest September quarter in years, with revenue rising 38% to $21.1 million and profit before tax climbing 30% to $4.4 million. Orbis growth, resilient consumables demand and the developing CGA business are giving the company several avenues for further expansion, although precious metals revenue included a low-margin one-off sale.

Prescient Therapeutics has reached the first planned review threshold in its PTX-100 Phase 2a lymphoma study, while a completed A$6.0 million raise extends funding beyond the December milestone. The review will assess safety and efficacy, but is not a study completion or a new clinical result.

American Tungsten & Antimony has produced one antimony ingot assaying 99.8% from US-mined material, meeting the highest ASTM B237 grade and exceeding the Regulus II specification. The result comes as the company pursues US government funding and offtake arrangements, although no commitments have been secured and AT4 does not yet control the relevant assets.

Perpetual Resources and adviser GreenMet are assessing several US Government funding and financing pathways for the Nevada Scheelite tungsten project, as Washington prepares tighter defence sourcing rules. The interest is strategic, but no funding has been secured and the project remains without a Mineral Resource or Ore Reserve.

Arafura Rare Earths has signed a binding five-year offtake agreement covering up to 850 tonnes a year of NdPr oxide at nameplate production. The deal expands on an earlier term sheet, but leaves pricing mechanics, counterparty identity and conditions precedent undisclosed.

GenusPlus will acquire New Zealand telecommunications construction and maintenance provider UCG for about NZ$40 million upfront and deferred consideration, with a further NZ$25 million tied to performance. The deal expands GenusPlus’s communications capability and is expected to be immediately earnings accretive, subject to regulatory and contractual approvals.

Iceni Gold has defined a new drilling corridor at Goose Well after diamond drilling confirmed broad, low-grade gold mineralisation with higher-grade quartz veins near the Gander Fault. The company is also preparing for a Gold Fields-funded 7,000m RC campaign at Everleigh, with results expected from December.

New Zealand Rural Land Company’s 75%-owned partnership has conditionally agreed to sell five Hawke’s Bay orchards for $18.84 million, as uncertainty from the Kiwi Crunch administration continues to cloud FY26 earnings. Completion depends on Overseas Investment Office consent.

Inghams Group Limited (ASX:ING) returned to poultry volume growth in FY26, but rising costs, a tax dispute and weaker earnings sharply reduced shareholder returns. The company enters FY27 with lower net debt, elevated leverage and a value-led turnaround strategy still to prove itself.

CVC Limited (ASX:CVC) ended FY26 with $87.7 million in cash after a major Laverton sale, debt refinancing and a decision to abandon a $124 million property settlement. The stronger liquidity position came alongside a 541.7% rise in underlying NPAT, although earnings remain dependent on lumpy property realisations and planning approvals.

L1 Global Long Short Fund has raised approximately A$100.9 million from institutional investors, with strong demand allowing L1 Group to place its A$70.1 million entitlement with new shareholders. Retail investors now face a 1-for-2 offer at A$1.76 a share, with up to A$381.7 million still available.

Servcorp Limited (ASX:SRV) has posted a third consecutive record year, with underlying profit, free cash flow and dividends all rising sharply. The debt-free workspace operator is guiding to another year of strong cash generation while investing in Saudi Arabia, technology and AI-enabled services.